EVENITY

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Estonia, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, UK.

Active ingredients

The drug EVENITY contains one active pharmaceutical ingredient (API):

1	Romosozumab UNII 3VHF2ZD92J - ROMOSOZUMAB
	Romosozumab is a humanized monoclonal antibody (IgG2) that binds and inhibits sclerostin, thereby increasing bone formation due to the activation of bone lining cells, increasing bone matrix production by osteoblasts, and recruitment of osteoprogenitor cells. Additionally, romosozumab results in changes to expression of osteoclast mediators, thereby decreasing bone resorption.
	Read more about Romosozumab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EVENITY Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)
EVENITY Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M05BX06		M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BX Other drugs affecting bone structure and mineralization
Discover more medicines within M05BX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	12301K
BR	Câmara de Regulação do Mercado de Medicamentos	544121030005402
CA	Health Products and Food Branch	02489597
EE	Ravimiamet	1808524, 1808535, 1808546, 1808557
GB	Medicines & Healthcare Products Regulatory Agency	381593
HK	Department of Health Drug Office	66741
IL	מִשְׂרַד הַבְּרִיאוּת	8507
JP	医薬品医療機器総合機構	3999449G1025
LT	Valstybinė vaistų kontrolės tarnyba	1089061, 1089063, 1089064, 1089065
NL	Z-Index G-Standaard, PRK	207063
PL	Rejestru Produktów Leczniczych	100429823, 100429830
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68906001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699862950244
US	FDA, National Drug Code	55513-880